Your doctor may prescribe a type of drug called a cholinesterase inhibitor, most commonly donepezil (Aricept), rivastigmine (Exelon), or galantamine (Razadyne). By blocking breakdown of an important ...

Exelon Corporation EXC is scheduled to release fourth-quarter 2024 results on Feb. 12, before market open. The company delivered an earnings surprise of 5.97% in the last reported quarter. Exelon ...

Major U.S. electric utility Exelon increased its four-year capital investment plan by 10% to $38 billion, with the bulk of the spending aimed at bolstering and building new transmission lines ...

Morgan Stanley analyst David Arcaro maintained a Hold rating on Exelon (EXC – Research Report) today and set a price target of $46.00. The company’s shares closed yesterday at $42.65.